Protective effects of disodium etidronate and pamidronate against the biomechanical repercussion of betamethasone-induced osteopenia in growing rat femurs.

[1]  P. Geusens,et al.  Longitudinal effect of tiludronate on bone mineral density, resonant frequency, and strength in monkeys , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  J. Zanchetta,et al.  Pamidronate and dimethyl-pamidronate effects on femur biomechanics in ovariectomized-hemisciaticectomized rats , 1992 .

[3]  K. Pritzker,et al.  The effect of pamidronate (APD) administration on canine bone , 1992 .

[4]  J. Ferretti,et al.  Biomechanical repercussion of differential anti-anabolic effects of deflazacort and betamethasone on body and bone growth in rats , 1992 .

[5]  J. Zanchetta,et al.  Tolerance of pamidronate (APD) soft capsules in 755 patients , 1992 .

[6]  J. Zanchetta,et al.  Biological determination of diaphyseal thickness according to mechanical quality of bone material in several vertebrate species , 1992 .

[7]  P. Geusens,et al.  Interest of biomechanical analysis in the experimental bone quality evaluation: The study of tiludronate as an example , 1992 .

[8]  H. Kawashima,et al.  Pharmacological profile of new bisphosphonate. 1-hydroxy-2-(imidazo[1,2-A]pyridin-3-YL)ethane-1,1-bis(phosphonic acid) , 1992 .

[9]  A. Parfitt.  Use of bisphosphonates in the prevention of bone loss and fractures. , 1991, The American journal of medicine.

[10]  S L Hui,et al.  Bone mass and anthropometric measurements in adult females. , 1990, Bone and mineral.

[11]  R. Capozza,et al.  Biomechanical effects of the full range of useful doses of (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) on femur diaphyses and cortical bone tissue in rats. , 1990, Bone and mineral.

[12]  C. Bozzini,et al.  Biomechanical performance of diaphyseal shafts and bone tissue of femurs from protein-restricted rats. , 1988, Bone and mineral.

[13]  I. Reid,et al.  PREVENTION OF STEROID-INDUCED OSTEOPOROSIS WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (APD) , 1988, The Lancet.

[14]  R. Riggins,et al.  Effect of Ethane-l-hydroxy-l,l-diphosphonate (EHDP) and Dietary Fluoride on Biomechanical and Morphological Changes in Chick Bone , 1977 .

[15]  D. Morgan,et al.  Effects of a diphophonate on calcium metabolism in calcium-deprived rats. , 1975, The American journal of physiology.

[16]  W. Jee,et al.  Corticosteroid and bone. , 1970, The American journal of anatomy.

[17]  B. Epker.  41 Studies on Bone Turnover and Balance in the Rabbit: I. Effects of Hydrocortisone , 1970, Clinical orthopaedics and related research.

[18]  R. Tomarelli,et al.  A salt mixture supplying the national research council estimates of the mineral requirements of the rat. , 1966, The Journal of nutrition.

[19]  R. Valkema,et al.  The use of bisphosphonates in the treatment of osteoporosis. , 1992, Bone.

[20]  L. S. Stern,et al.  Aminohydroxybutane bisphosphonate prevents bone loss in a rat model of simulated weightlessness , 1991 .

[21]  R. Martin,et al.  Determinants of the mechanical properties of bones. , 1991, Journal of biomechanics.

[22]  H. Shinoda,et al.  Effect of HEBP (1-hydroxyethylidene-1,1-bisphosphonate) on experimental osteoporosis induced by ovariectomy in rats. , 1991, Japanese journal of pharmacology.

[23]  M. Davie,et al.  Effect of the biphosphonate EHDP on mechanical properties of normal and osteopetrotic bone , 1987 .

[24]  J. Compston,et al.  Trabecular bone mineral content, volume and structure in patients with chronic, active rheumatoid arthritis , 1987 .

[25]  K. Lindenhayn,et al.  On the action of prednisolone and ethane-1-hydroxy-1,1-diphosphonate (EHDP) on rabbit bone. , 1982, Experimental pathology.

[26]  G. H. Bell.  BONE AS A MECHANICAL ENGINEERING PROBLEM , 1956 .